Nitorum Capital »

United Therapeutics Corporation shares owned by Nitorum Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Nitorum Capital from 13F filings

Historical chart of Nitorum Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Nitorum Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Nitorum Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 122k 219.89
2023-09-30 $25M 112k 225.87

More positions owned by Nitorum Capital

Churchill Downs (CHDN)
Martin Marietta Materials (MLM)
Fidelity National Information Services (FIS)
Cannae Holdings (CNNE)
Mastercard Incorporated Cl A (MA)
Fiserv (FI)
Msc Indl Direct Cl A (MSM)
Bio Rad Labs Cl A (BIO)
Primo Water (PRMW)
Mannkind Corp Com New (MNKD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
FTI Consulting (FCN)
Boyd Gaming Corporation (BYD)
Gentex Corporation (GNTX)
eBay (EBAY)

View all positions for Nitorum Capital

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
Bank of New York Mellon
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Nordea Investment Management Ab
Caisse de depot et placement du Quebec

View all funds holding United Therapeutics Corporation